Xiaoliang Wang

1.6k citations
41 papers · 821 indexed · h-index 16
Topics
MicroRNA in disease regulation (5 papers)RNA Interference and Gene Delivery (4 papers)RNA modifications and cancer (4 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Xiaoliang Wang

40 papers receiving 808 citations

Peers

Xiaoliang Wang
Comparison fields: 5 of 113
  • Molecular Biology 500
  • Cancer Research 171
  • Immunology 76
  • Cardiology and Cardiovascular Medicine 73
  • Epidemiology 71
Replace Shuxu Yang with:
Shuxu Yang China
Li Ba China
Yun Xu China
Shujun Feng China
He Huang China
Qi Shen China
Annalucia Carbone Italy
Jun Ju China
Guofeng Bao China
Xiaoliang Wang relative to Shuxu Yang China Shuxu Yang's profile →
Citations per field
00.5×9.1×
Shuxu Yang · 1×
Citations per year

Countries citing papers authored by Xiaoliang Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaoliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoliang Wang more than expected).

Fields of papers citing papers by Xiaoliang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoliang Wang. The network helps show where Xiaoliang Wang may publish in the future.

Co-authorship network of co-authors of Xiaoliang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoliang Wang. A scholar is included among the top collaborators of Xiaoliang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoliang Wang. Xiaoliang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 2
4 0
5 8
6 28
7 3
8 7
9 28
10 3
11 17
12 3
13 40
14 7
15 9
16 29
17 21
18 40
19 34
20
Alpha 1A- and alpha 1B-adrenoceptor-mediated positive chronotropic effects on isolated rat atrium.
2

About Xiaoliang Wang

Xiaoliang Wang is a scholar working on Biological Psychiatry, Behavioral Neuroscience and Cancer Research, having authored 41 papers that have together received 821 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), RNA Interference and Gene Delivery (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (171 citations), Biological Psychiatry (20 citations) and Molecular Biology (500 citations). Xiaoliang Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Hongchen Gu, Yongjie Ma, Linzhu Zhou, Li Xu, Huamei Tang, Guoqiang Qiu, Junwei Fan, Zhihai Peng, Xing Sun and Xiaoli Wang. Their work appears in journals such as Circulation Research, Biochemical and Biophysical Research Communications and Neuropsychologia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026